Follow-up data are from a study being conducted in @ sites in Colombia designed to evaluate the long-term immunogenicity , effectiveness , and safety of the qHPV vaccine in women who were vaccinated at @ to @ years of age ( in the original vaccine group during the base study -LSB- n = @ -RSB- ) or @ to @ years of age ( in the original placebo group during the base study -LSB- n = @ -RSB- ) .